SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-24-000026
Filing Date
2024-02-29
Accepted
2024-02-29 08:03:32
Documents
16
Period of Report
2024-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20240226.htm   iXBRL 8-K 30029
2 EX-99.1 pcrx-12312023x991.htm EX-99.1 357601
6 PACIRA BIOSCIENCES LOGO pacirabiosciencesa03.jpg GRAPHIC 27796
  Complete submission text file 0001396814-24-000026.txt   584637

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20240226.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20240226_lab.xml EX-101.LAB 24134
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20240226_pre.xml EX-101.PRE 12518
17 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20240226_htm.xml XML 2733
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 24698970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)